Diabetes, Vol 35, Issue 6 642-648, Copyright © 1986 by American Diabetes Association

ARTICLES

Effects of hyperglycemia on glucose production and utilization in humans. Measurement with [23H]-, [33H]-, and [614C]glucose

PM Bell, RG Firth and RA Rizza

Studies with tritiated isotopes of glucose have demonstrated that hyperglycemia per se stimulates glucose utilization and suppresses glucose production in humans. These conclusions rely on the assumption that tritiated glucose provides an accurate measure of glucose turnover. However, if in the presence of hyperglycemia the isotope either loses its label during "futile" cycling or retains its label during cycling through glycogen, then this assumption is not valid. To examine this question, glucose utilization and glucose production rates were measured in nine normal subjects with a simultaneous infusion of [23H]glucose, an isotope that may undergo futile cycling but does not cycle through glycogen; [614C]glucose, an isotope that may cycle through glycogen but does not futile cycle; and [33H]glucose, an isotope that can both undergo futile cycling and cycle through glycogen. In the postabsorptive state at plasma glucose concentration of 95 mg X dl-1, glucose turnover determined with [614C]glucose (2.3 +/- 0.1 mg X kg-1 X min-1) was greater than that determined with [33H]glucose (2.1 +/- 0.1 mg X kg-1 X min-1, P = 0.002) and slightly less than that determined with [23H]glucose (2.7 +/- 0.2 mg X kg-1 X min-1, P = 0.08). Plasma glucose was then raised from 95 to 135 to 175 mg X dl-1 while insulin secretion was inhibited, and circulating insulin, glucagon, and growth hormone concentrations were maintained constant by infusion of these hormones and somatostatin. Glucose production and utilization rates determined with [614C]glucose continued to be less than those determined with [23H]glucose and greater than those seen with [33H]glucose.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. T. Fueger, C. Y. Li, J. E. Ayala, J. Shearer, D. P. Bracy, M. J. Charron, J. N. Rottman, and D. H. Wasserman Glucose kinetics and exercise tolerance in mice lacking the GLUT4 glucose transporter J. Physiol., July 15, 2007; 582(2): 801 - 812. [Abstract] [Full Text] [PDF]

				L. Juurinen, M. Tiikkainen, A.-M. Hakkinen, A. Hakkarainen, and H. Yki-Jarvinen Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E829 - E835. [Abstract] [Full Text] [PDF]

				P. Kishore, J. Tonelli, S. Koppaka, C. Fratila, A. Bose, D.-E. Lee, K. Reddy, and M. Hawkins Time-Dependent Effects of Free Fatty Acids on Glucose Effectiveness in Type 2 Diabetes Diabetes, June 1, 2006; 55(6): 1761 - 1768. [Abstract] [Full Text] [PDF]

				V. Rigalleau, M.-C. Beauvieux, J.-L. Gallis, H. Gin, P. Schneiter, and L. Tappy Effects of hyperglycemia on glucose metabolism before and after oral glucose ingestion in normal men Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1198 - E1204. [Abstract] [Full Text] [PDF]

				M. C. Riddle and D. J. Drucker Emerging Therapies Mimicking the Effects of Amylin and Glucagon-Like Peptide 1 Diabetes Care, February 1, 2006; 29(2): 435 - 449. [Full Text] [PDF]

				C. Schlumbohm and J. Harmeyer Hyperketonemia Impairs Glucose Metabolism in Pregnant and Nonpregnant Ewes J Dairy Sci, February 1, 2004; 87(2): 350 - 358. [Abstract] [Full Text] [PDF]

				M. Hawkins, J. Tonelli, P. Kishore, D. Stein, E. Ragucci, A. Gitig, and K. Reddy Contribution of Elevated Free Fatty Acid Levels to the Lack of Glucose Effectiveness in Type 2 Diabetes Diabetes, November 1, 2003; 52(11): 2748 - 2758. [Abstract] [Full Text] [PDF]

				F. Fery, J. Deviere, and E. O. Balasse Metabolic handling of intraduodenal vs. intravenous glucose in humans Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E261 - E268. [Abstract] [Full Text] [PDF]

				M. Mevorach, J. Kaplan, C. J. Chang, L. Rossetti, and H. Shamoon Hormone-independent activation of EGP during hypoglycemia is absent in type 1 diabetes mellitus Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E421 - E429. [Abstract] [Full Text] [PDF]